BerandaHESTERBIO • NSE
add
Hester Biosciences Ltd
Tutup sebelumnya
₹1.736,60
Rentang hari
₹1.689,10 - ₹1.809,00
Rentang tahun
₹1.242,95 - ₹3.379,00
Kapitalisasi pasar
15,24Â M INR
Volume Rata-Rata
62,61Â rb
Rasio P/E
48,34
Hasil dividen
0,34%
Bursa utama
NSE
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
(INR) | Des 2024info | Perubahan Y/Y |
---|---|---|
Pendapatan | 710,27Â jt | 4,49% |
Biaya operasional | 428,23Â jt | 7,22% |
Laba bersih | 116,62Â jt | 192,72% |
Margin laba bersih | 16,42 | 180,20% |
Penghasilan per saham | — | — |
EBITDA | 127,96Â jt | 2,42% |
Tarif pajak efektif | 14,65% | — |
Neraca
Total aset
Total liabilitas
(INR) | Des 2024info | Perubahan Y/Y |
---|---|---|
Investasi tunai jangka pdk | 167,88Â jt | 16,16% |
Total aset | — | — |
Total liabilitas | — | — |
Total ekuitas | 3,14 M | — |
Saham yang beredar | 8,70 jt | — |
Harga terhadap nilai buku | 4,78 | — |
Tingkat pengembalian aset | — | — |
Tingkat pengembalian modal | 3,84% | — |
Arus Kas
Perubahan kas bersih
(INR) | Des 2024info | Perubahan Y/Y |
---|---|---|
Laba bersih | 116,62Â jt | 192,72% |
Kas dari operasi | — | — |
Kas dari investasi | — | — |
Kas dari pembiayaan | — | — |
Perubahan kas bersih | — | — |
Arus kas bebas | — | — |
Tentang
Hester Biosciences Limited is a publicly traded Indian animal and poultry vaccines manufacturing company, headquartered in Ahmedabad. Hester has plants situated in Gujarat and Nepal. Hester has a 30% share of the poultry vaccines market in India, making it the country's second largest poultry vaccine manufacturer. Hester is also the first commercial manufacturer of goat pox vaccine in India and manufactures PPR vaccines from both, Nigerian and Sungri strains. Wikipedia
Didirikan
1983
Situs
Karyawan
642